feed rss
decorazione
Star Alliance

FREE COMMUNICATION 06

 

ROOM HISAR      14:30 - 16:00
  

 

Cardiovascular disease in CKD

 

 

Chair: Carlo Basile, Taranto, Italy 

 

 

FREE COMMUNICATIONS


SO035
ASSOCIATION OF MAGNESIUM LEVEL WITH REDUCED CARDIOVASCULAR MORTALITY IN INCIDENT DIALYSIS PATIENTS
Johanna S Van Den Broek,1 Tiny Hoekstra,2 Christiane Drechsler, 4 Vincent M Brandenburg,3 Friedo W Dekker,2 Marc G Vervloet.1 1Dept Nephrology, VU Medical Center, Amsterdam, Netherlands; 2Dept Clinical Epidemiology, Leiden Univ Medical Center, Leiden, Netherlands; 3Dept Cardiology, Univ Hosp RWTH, Aachen, Germany; 4Dept Internal Medicine 1, Div Nephrology, Univ Würzburg, Würzburg, Germany.

SO036
MIR-155 PBMC EXPRESSION IN CHRONIC HEMODIALYSIS PATIENTS WITH CARDIOVASCULAR RISK
Paolo Albrizio,3 Vincenzo Sepe,1 Massimiliano Gnecchi,2 Elisabetta Cervio,2 Filippo Mangione,1 Fulvio Fiorini,4 Teresa Rampino,1 Carmelo Libetta,3 Antonio Dal Canton.3 1Unit Nephrology, Dialysis and Transplantation, 2Coronary Intensive Care Unit, Fond IRCCS Policlinico San Matteo, Pavia, Italy; 3Chair Nephrology, Univ Pavia, Pavia, Italy; 4Nefrology, dialysis and dietology, Osp SM della Misericordia, Rovigo, Italy.
 
SO037
SOLUBLE FLT-1 CONTRIBUTES TO CARDIOVASCULAR DISEASE IN CKD
Giovana Di Marco,1 Stefan Reuter,1 Dominik Kentrup,1 Klaus Tiemann,2 Manfred Fobker,1 Christiane Engelbertz,1 Günter Breithardt,1 Holger Reinecke,1 Eva Brand,1 Hermann Pavenstädt,1 Marcus Brand.1 1Universitätsklinikum Münster, Münster, Germany; 2Isar Medizin Zentrum, München, Germany.
 
SO038
VITAMIN K ANTAGONISTS ARE AN INDIPENDENT RISK FACTOR FOR UREMIC FOOT AND DEATH AMONG DIALYZED PATIENTS
Andreana De Mauri, Novella Conti, Doriana Chiarinotti, Paola David, Federica Capurro, Martino De Leo. Nephrology and Dialysis Unit, Univ Hosp Maggiore della Carità, Novara, Italy.

SO039
VITAMIN K ANTAGONISTS IN HEMODIALYSIS PATIENTS: IMPACT ON THE PLASMA LEVELS OF DEPHOSPHO- UNCARBOXYLATED MATRIX GLA-PROTEIN
Pierre Delanaye,1 Jean-Marie Krzesinski,1 Xavier Warling,3 Nicole Smelten,4 Etienne Cavalier.2 1Nephrology Dialysis Transplantation, 2Clinical Chemistry, CHU Sart Tilman, Univ Liège, Liège, Belgium; 3Dialysis- Nephrology, Centre Hosp Régional, La Citadelle, Liège, Belgium; 4Nephrology-Dialysis, Centre Hosp du Bois de l’Abbaye, Seraing, Belgium.
 
SO040
SAFETY OF WARFARIN USE IN CHRONIC HEMODIALYSIS PATIENTS: A PROSPECTIVE COHORT STUDY
Matsuhiko Hayashi,1 Yoshihiko Kanno,1 Mieko Iwai,1 Tadashi Yoshida,1 Takayuki Abe.2 1Apheresis and Dialysis Center, 2Center Clinical Research, Univ Keio, School Medicine, Shinjuku-ku, Tokuyo, Japan.


back to the timetable

 

final programme "day by day" - may 18 - 21, 2013

today